Ameriflex and Aflac Partner to Deliver Seamless Consumer Directed Health Care Administration in the Public Sector Market
Aflac (NYSE:AFL) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
Wrap up more than a story: Aflac's "Beyond Words" is the perfect gift that gives back
Aflac expands support for children with new book 'Beyond Words'
Aflac (NYSE:AFL) had its price target raised by analysts at Morgan Stanley from $113.00 to $118.00. They now have an "equal weight" rating on the stock.